{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:40:45Z","timestamp":1792773645446,"version":"4.5.0"},"reference-count":260,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370709"],"award-info":[{"award-number":["82370709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570833"],"award-info":[{"award-number":["82570833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2024YFC2511000"],"award-info":[{"award-number":["2024YFC2511000"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2017-26-2202-2"],"award-info":[{"award-number":["Z-2017-26-2202-2"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024IR35"],"award-info":[{"award-number":["2024IR35"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2022CR41"],"award-info":[{"award-number":["2022CR41"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["YPZ-41"],"award-info":[{"award-number":["YPZ-41"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.gendis.2026.102226","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:13:53Z","timestamp":1778109233000},"page":"102226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic kidney diseases: Decoding molecular taxonomies to drive precision nephrology and therapeutic innovation"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8756-9803","authenticated-orcid":false,"given":"Zhi-ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7215-707X","authenticated-orcid":false,"given":"Xu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMra2308577","article-title":"Genetics of chronic kidney disease","volume":"391","author":"Vivante","year":"2024","journal-title":"N Engl J Med"},{"issue":"6562","key":"10.1016\/j.gendis.2026.102226_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1126\/science.abl5403","article-title":"The legacy of the human genome project","volume":"373","author":"Rood","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2019.02.003","article-title":"Genomic medicine\u2013Progress, pitfalls, and promise","volume":"177","author":"Shendure","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7326\/L18-0035","article-title":"Whole-exome sequencing in adults with chronic kidney disease: a pilot study","volume":"168","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.kint.2019.01.038","article-title":"Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease","volume":"96","author":"Ottlewski","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000504869","article-title":"Utility of genomic testing after renal biopsy","volume":"51","author":"Murray","year":"2020","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41436-020-00963-4","article-title":"Clinical impact of genomic testing in patients with suspected monogenic kidney disease","volume":"23","author":"Jayasinghe","year":"2021","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ndt\/gfz173","article-title":"Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases","volume":"36","author":"Mansilla","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib11","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M18-1241","article-title":"The burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing","volume":"170","author":"Rasouly","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfab218","article-title":"Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice","volume":"37","author":"Knoers","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ndt\/gfz028","article-title":"Personalized medicine in chronic kidney disease by detection of monogenic mutations","volume":"35","author":"Connaughton","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneph.2015.205","article-title":"Exploring the genetic basis of early-onset chronic kidney disease","volume":"12","author":"Vivante","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib17","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib18","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"22","key":"10.1016\/j.gendis.2026.102226_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146643","article-title":"Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","article-title":"Genetics in chronic kidney disease: conclusions from a Kidney Disease: improving global outcomes (KDIGO) controversies conference","volume":"101","author":"K\u00f6ttgen","year":"2022","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/cge.13606","article-title":"Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system","volume":"96","author":"Rao","year":"2019","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.ajkd.2023.06.006","article-title":"Genetic markers among the Israeli druze minority population with end-stage kidney disease","volume":"83","author":"Shlomovitz","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfaa363","article-title":"Genetics-first approach improves diagnostics of ESKD patients <50 years old","volume":"37","author":"Snoek","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ekir.2020.10.030","article-title":"Attitudes and practices of Australian nephrologists toward implementation of clinical genomics","volume":"6","author":"Jayasinghe","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.xkme.2021.08.006","article-title":"Genetic testing for chronic kidney diseases: clinical utility and barriers perceived by nephrologists","volume":"3","author":"Mrug","year":"2021","journal-title":"Kidney Med"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2215\/CJN.12481019","article-title":"Pilot study of return of genetic results to patients in adult nephrology","volume":"15","author":"Nestor","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ajmg.c.32004","article-title":"Incorporating genetics services into adult kidney disease care","volume":"190","author":"Bogyo","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100814","article-title":"The effect of genetic education on the referral of patients to genetic evaluation: findings from a national survey of nephrologists","volume":"25","author":"Rasouly","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.gendis.2026.102226_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1101\/SQB.1953.018.01.020","article-title":"The structure of DNA","volume":"18","author":"Watson","year":"1953","journal-title":"Cold Spring Harbor Symp Quant Biol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib30","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7011","key":"10.1016\/j.gendis.2026.102226_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","year":"2004","journal-title":"Nature"},{"issue":"7676","key":"10.1016\/j.gendis.2026.102226_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature24286","article-title":"DNA sequencing at 40: past, present and future","volume":"550","author":"Shendure","year":"2017","journal-title":"Nature"},{"issue":"7726","key":"10.1016\/j.gendis.2026.102226_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.kint.2020.03.031","article-title":"Genetic testing for kidney disease of unknown etiology","volume":"98","author":"Hays","year":"2020","journal-title":"Kidney Int"},{"issue":"9931","key":"10.1016\/j.gendis.2026.102226_bib35","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/S0140-6736(14)60659-0","article-title":"Rare inherited kidney diseases: challenges, opportunities, and perspectives","volume":"383","author":"Devuyst","year":"2014","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.gendis.2026.102226_bib36","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2025.0310","article-title":"Autosomal dominant polycystic kidney disease: a review","volume":"333","author":"Chebib","year":"2025","journal-title":"JAMA"},{"issue":"10174","key":"10.1016\/j.gendis.2026.102226_bib37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.kint.2019.10.027","article-title":"The CKDGen consortium: ten years of insights into the genetic basis of kidney function","volume":"97","author":"K\u00f6ttgen","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s40620-025-02207-7","article-title":"Polygenic risk scores for eGFR are associated with age at kidney failure","volume":"38","author":"Collins","year":"2025","journal-title":"J Nephrol"},{"issue":"26","key":"10.1016\/j.gendis.2026.102226_bib40","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMc1800748","article-title":"Worldwide frequencies of APOL1 renal risk variants","volume":"379","author":"Nadkarni","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MNH.0000000000000462","article-title":"Dilemmas and challenges in apolipoprotein L1 nephropathy research","volume":"28","author":"Kruzel-Davila","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib42","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.kint.2021.09.019","article-title":"UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease","volume":"100","author":"Turner","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139927","article-title":"Biomarkers of inflammation and repair in kidney disease progression","volume":"131","author":"Puthumana","year":"2021","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib44","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib45","first-page":"40","article-title":"Renal replacement therapy in autosomal dominant polycystic kidney disease","volume":"57","author":"Singh","year":"2004","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00467-012-2272-z","article-title":"An update on the pathomechanisms and future therapies of Alport syndrome","volume":"28","author":"Noone","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib49","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management: a KDIGO consensus report","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib52","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib54","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","article-title":"Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders","volume":"92","author":"Mallett","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib55","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/ndt\/gfaf092","article-title":"Chronic kidney disease of unexplained cause (CKDx): a consensus statement by the genes & kidney working group of the ERA","volume":"40","author":"Halbritter","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.kint.2024.11.028","article-title":"International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations eGFR epidemiology (DEGREE) study","volume":"107","author":"Rutter","year":"2025","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41581-025-00935-4","article-title":"Insights into the burden of CKDu","volume":"21","author":"Allison","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib58","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2024.04.021","article-title":"Genetic characterization of kidney failure of unknown etiology in Spain: findings from the GENSEN study","volume":"84","author":"Blasco","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12199-015-0475-1","article-title":"Whole-exome sequencing reveals genetic variants associated with chronic kidney disease characterized by tubulointerstitial damages in north central region, Sri Lanka","volume":"20","author":"Nanayakkara","year":"2015","journal-title":"Environ Health Prev Med"},{"issue":"8","key":"10.1016\/j.gendis.2026.102226_bib60","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/tmi.13913","article-title":"Chronic kidney disease of unknown aetiology: a comprehensive review of a global public health problem","volume":"28","author":"Rao","year":"2023","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.gendis.2026.102226_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41439-018-0016-8","article-title":"Novel variants in COL4A4 and COL4A5 are rare causes of FSGS in two unrelated families","volume":"5","author":"Hines","year":"2018","journal-title":"Hum Genome Var"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib62","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/TP.0000000000004363","article-title":"Incorporation of genetic studies in the kidney transplant evaluation clinic: the value of a multidisciplinary approach","volume":"107","author":"El Ters","year":"2023","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib63","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1038\/s41598-017-11838-1","article-title":"Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-140-7-200404060-00009","article-title":"Clinical spectrum associated with hepatocyte nuclear factor-1\u03b2 mutations","volume":"140","author":"Bellann\u00e9-Chantelot","year":"2004","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib65","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.06810909","article-title":"Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases","volume":"5","author":"Heidet","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1681\/ASN.2015050544","article-title":"Hepatocyte nuclear factor 1\u03b2-associated kidney disease: more than renal cysts and diabetes","volume":"27","author":"Verhave","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jmg.2005.032854","article-title":"Mutations in hepatocyte nuclear factor-1\u03b2 and their related phenotypes","volume":"43","author":"Edghill","year":"2006","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrneph.2014.232","article-title":"HNF1B-associated renal and extra-renal disease: an expanding clinical spectrum","volume":"11","author":"Clissold","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib70","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ki.2014.305","article-title":"Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis","volume":"86","author":"Malone","year":"2014","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib71","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","volume":"24","author":"Pierides","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib73","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib75","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","article-title":"International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people","volume":"15","author":"Gimpel","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00467-017-3801-6","article-title":"Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center","volume":"33","author":"Tan","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib78","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","article-title":"Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin","volume":"41","author":"Bertelli","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2215\/CJN.04120417","article-title":"Whole exome sequencing of patients with steroid-resistant nephrotic syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020167","article-title":"\u03b1-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein","volume":"2","author":"Yao","year":"2004","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib81","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1172\/JCI69000","article-title":"ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption","volume":"123","author":"Ashraf","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib82","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.kint.2022.02.040","article-title":"Variation of the clinical spectrum and genotype-phenotype associations in coenzyme Q10 deficiency associated glomerulopathy","volume":"102","author":"Drovandi","year":"2022","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.gendis.2026.102226_bib83","article-title":"COQ8B nephropathy: early detection and optimal treatment","volume":"8","author":"Song","year":"2020","journal-title":"Mol Genet Genom Med"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib84","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.kint.2022.04.029","article-title":"Oral coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary coenzyme Q10 deficiency","volume":"102","author":"Drovandi","year":"2022","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib85","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00018-024-05499-3","article-title":"Regulation of formin INF2 and its alteration in INF2-linked inherited disorders","volume":"81","author":"Labat-de-Hoz","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib86","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00467-023-06174-8","article-title":"Nephronophthisis: a pathological and genetic perspective","volume":"39","author":"Wolf","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.kint.2024.04.022","article-title":"Nephronophthisis-associated ciliopathy with brachydactyly, medullary cysts, and chronic kidney disease","volume":"106","author":"Chen","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib88","first-page":"316","article-title":"Nephronophthisis-medullary cystic kidney disease: from bedside to bench and back again","volume":"14","author":"Scolari","year":"2003","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib89","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcp.30788","article-title":"Association of novel TMEM67 variants with mild phenotypes of high gamma-glutamyl transpeptidase cholestasis and congenital hepatic fibrosis","volume":"237","author":"Qiu","year":"2022","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib90","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/humu.24251","article-title":"A discarded synonymous variant in NPHP3 explains nephronophthisis and congenital hepatic fibrosis in several families","volume":"42","author":"Olinger","year":"2021","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib91","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.2006121344","article-title":"Nephronophthisis-associated ciliopathies","volume":"18","author":"Hildebrandt","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jmg.2010.082552","article-title":"Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy","volume":"48","author":"Otto","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.gendis.2026.102226_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107940","article-title":"Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes","volume":"193","author":"George","year":"2020","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100956","article-title":"INVS mutation-related NPHP2 nephronophthisis with glomerulocystic disease: a case report","volume":"7","author":"Sawada","year":"2025","journal-title":"Kidney Med"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5414\/CNP69135","article-title":"Association of INVS (NPHP2) mutation in an adolescent exhibiting nephronophthisis (NPH) and complete situs inversus","volume":"69","author":"Okada","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.gendis.2026.102226_bib96","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fped.2017.00287","article-title":"Many genes: one disease? Genetics of nephronophthisis (NPHP) and NPHP-associated disorders","volume":"5","author":"Srivastava","year":"2018","journal-title":"Front Pediatr"},{"issue":"22","key":"10.1016\/j.gendis.2026.102226_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212253","article-title":"The role of centrosome distal appendage proteins (DAPs) in nephronophthisis and ciliogenesis","volume":"22","author":"Mansour","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2S","key":"10.1016\/j.gendis.2026.102226_bib98","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","author":"Devuyst","year":"2025","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib99","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1681\/ASN.2013101103","article-title":"Mild recessive mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract","volume":"25","author":"Kohl","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.gendis.2026.102226_bib100","first-page":"A94.1","article-title":"O-182 Hnf1b mutations in patients with congenital abnormalities of kidney and urinary tract (cakut): are we screening too much?","volume":"99","author":"Raaijmakers","year":"2014","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib101","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2215\/CJN.10221012","article-title":"Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes","volume":"8","author":"Madariaga","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.gendis.2026.102226_bib102","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/hmg\/dds141","article-title":"Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis","volume":"21","author":"Paces-Fessy","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gendis.2026.102226_bib103","article-title":"The evaluation of genetic diagnosis on high-risk fetal CAKUT","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000478-200202000-00006","article-title":"Renal disease in adults with TSC2\/PKD1 contiguous gene syndrome","volume":"26","author":"Martignoni","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2009.440","article-title":"Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease","volume":"77","author":"Denamur","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib107","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in Alport syndrome (COL4A3\u2013COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib108","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib109","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib110","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","article-title":"COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome","volume":"61","author":"Longo","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib111","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.kint.2024.01.036","article-title":"Quantitative assessment of glomerular basement membrane collagen IV \u03b1 chains in paraffin sections from patients with focal segmental glomerulosclerosis and Alport gene variants","volume":"105","author":"Puapatanakul","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib113","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2022.04.031","article-title":"Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases","volume":"102","author":"Wopperer","year":"2022","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2018.03.019","article-title":"Autosomal dominant tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1","volume":"72","author":"Ayasreh","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib116","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.ekir.2023.08.008","article-title":"Diagnostic yield and benefits of whole exome sequencing in CAKUT patients diagnosed in the first thousand days of life","volume":"8","author":"Werfel","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"19","key":"10.1016\/j.gendis.2026.102226_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910609","article-title":"HNF1B transcription factor: key regulator in renal physiology and pathogenesis","volume":"25","author":"S\u00e1nchez-Cazorla","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib118","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2014040388","article-title":"Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis","volume":"26","author":"Halbritter","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib119","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1523-1755.2002.kid552.x","article-title":"Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes","volume":"62","author":"Botzenhart","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2017.06.025","article-title":"Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis","volume":"93","author":"Daga","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.kint.2020.06.035","article-title":"Cystinuria: clinical practice recommendation","volume":"99","author":"Servais","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib122","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1523-1755.2000.00198.x","article-title":"Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease","volume":"58","author":"Igarashi","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int"},{"issue":"9647","key":"10.1016\/j.gendis.2026.102226_bib124","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib125","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib126","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41431-020-0677-x","article-title":"Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-Life data","volume":"28","author":"Riccio","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib127","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/healthcare11040449","article-title":"Fabry disease: switch from enzyme replacement therapy to oral chaperone migalastat: what do we know today?","volume":"11","author":"Perretta","year":"2023","journal-title":"Healthcare"},{"issue":"Suppl 4","key":"10.1016\/j.gendis.2026.102226_bib128","first-page":"S44","article-title":"Complement-driven hemolytic uremic syndrome","volume":"98","author":"Leon","year":"2023","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib129","doi-asserted-by":"crossref","first-page":"659","DOI":"10.34067\/KID.0000000000000115","article-title":"Clinical profiles and patterns of kidney disease progression in C3 glomerulopathy","volume":"4","author":"Caravaca-Font\u00e1n","year":"2023","journal-title":"Kidney360"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib132","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/j.ajkd.2018.05.006","article-title":"TREX1 mutation causing autosomal dominant thrombotic microangiopathy and CKD: a novel presentation","volume":"72","author":"Gulati","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib133","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cei\/uxad017","article-title":"TREX1 cytosolic DNA degradation correlates with autoimmune disease and cancer immunity","volume":"211","author":"Fang","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib134","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cge.12388","article-title":"Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene","volume":"87","author":"Moalem","year":"2015","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ajmg.c.31964","article-title":"Biallelic variants in TTC21B as a rare cause of early-onset arterial hypertension and tubuloglomerular kidney disease","volume":"190","author":"Olinger","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib136","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneph.2015.214","article-title":"Mitochondrial dysfunction in inherited renal disease and acute kidney injury","volume":"12","author":"Emma","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib137","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CN107063","article-title":"Renal involvement in MELAS syndrome\u2014A series of 5 cases and review of the literature","volume":"80","author":"Seidowsky","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.gendis.2026.102226_bib138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2014.05.005","article-title":"Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective","volume":"17","author":"Chin","year":"2014","journal-title":"Mitochondrion"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib139","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.bbadis.2018.09.002","article-title":"CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway","volume":"1864","author":"Kleiner","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9569","key":"10.1016\/j.gendis.2026.102226_bib140","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib141","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3\u2013COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib142","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2215\/CJN.01190210","article-title":"Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome","volume":"5","author":"B\u00fcscher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib143","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa2308695","article-title":"Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria","volume":"390","author":"Peffault de Latour","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib144","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12882-018-1107-y","article-title":"Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease","volume":"19","author":"Gast","year":"2018","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib146","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00559.x","article-title":"Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families","volume":"65","author":"Kudo","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib147","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajmg.c.32008","article-title":"Autosomal dominant tubulointerstitial kidney disease: a review","volume":"190","author":"\u017divn\u00e1","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib148","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.ajkd.2019.02.007","article-title":"APOL1 genetic testing in living kidney transplant donors","volume":"74","author":"Mohan","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib149","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.gendis.2026.102226_bib150","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1016\/j.cell.2024.04.046","article-title":"Structure-based discovery of CFTR potentiators and inhibitors","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.202103-0674ED","article-title":"CFTR modulators to the rescue of individuals with cystic fibrosis and advanced lung disease","volume":"204","author":"Myerburg","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib152","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.ajkd.2024.05.010","article-title":"Advancing genetic testing in kidney diseases: report from a national kidney foundation working group","volume":"84","author":"Franceschini","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib153","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib154","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","article-title":"A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases","volume":"94","author":"Bullich","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib155","article-title":"Genome-wide sequencing and the clinical diagnosis of genetic disease: the CAUSES study","volume":"3","author":"Elliott","year":"2022","journal-title":"HGG Adv"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib156","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13073-022-01069-z","article-title":"Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications","volume":"14","author":"Schobers","year":"2022","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib157","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41576-023-00683-w","article-title":"The expanding diagnostic toolbox for rare genetic diseases","volume":"25","author":"Kernohan","year":"2024","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib158","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ki.2015.319","article-title":"Prioritization and burden analysis of rare variants in 208 candidate genes suggest they do not play a major role in CAKUT","volume":"89","author":"Nicolaou","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib159","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.kint.2024.06.031","article-title":"Prenatal and preimplantation genetic testing for monogenic kidney disorders","volume":"107","author":"Knoers","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib161","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1002\/cphg.93","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines","volume":"103","author":"Harrison","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib162","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","article-title":"Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium","volume":"98","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib163","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype\u2013phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib164","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrneph.2017.167","article-title":"Genomic medicine for kidney disease","volume":"14","author":"Groopman","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41440-018-0116-3","article-title":"Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Mishima","year":"2019","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib166","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib167","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/ndt\/gfae060","article-title":"How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?","volume":"39","author":"Vallon","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"10365","key":"10.1016\/j.gendis.2026.102226_bib168","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib169","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska","year":"2017","journal-title":"Kidney Int"},{"issue":"10364","key":"10.1016\/j.gendis.2026.102226_bib171","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome","volume":"400","author":"Michael","year":"2022","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.gendis.2026.102226_bib172","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib173","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.06440616","article-title":"Pathogenic variants in complement genes and risk of atypical hemolytic uremic syndrome relapse after eculizumab discontinuation","volume":"12","author":"Fakhouri","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib174","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00467-018-4091-3","article-title":"Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib175","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1111\/j.1600-6143.2005.01045.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Wetzels","year":"2005","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib176","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib177","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib178","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome","volume":"20","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib179","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with Non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib181","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.gendis.2026.102226_bib182","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and kidney disease: from genetics to biology","volume":"82","author":"Friedman","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib183","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of black living donors","volume":"29","author":"Doshi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib184","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib185","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/j.1600-6143.2007.01921.x","article-title":"Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs","volume":"7","author":"Rodrigue","year":"2007","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib186","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/tid.12199","article-title":"Education and informed consent about increased risk donor kidneys: a national survey of non-physician transplant providers","volume":"16","author":"Gordon","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib187","doi-asserted-by":"crossref","first-page":"c31","DOI":"10.1159\/000320889","article-title":"Uromodulin-associated kidney disease","volume":"118","author":"Bleyer","year":"2010","journal-title":"Nephron Clin Pract"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib188","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2215\/CJN.00580116","article-title":"Alport syndrome in women and girls","volume":"11","author":"Savige","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib189","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.fertnstert.2018.04.003","article-title":"RETIRED: use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion","volume":"109","author":"Daar","year":"2018","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib191","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib192","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib193","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.amjmed.2016.02.010","article-title":"Appropriateness: a key to enabling the use of genomics in clinical practice?","volume":"129","author":"Vassy","year":"2016","journal-title":"Am J Med"},{"issue":"17","key":"10.1016\/j.gendis.2026.102226_bib194","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ndt\/gfab268","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease","volume":"38","author":"Mabillard","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib196","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"25","key":"10.1016\/j.gendis.2026.102226_bib197","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.gendis.2026.102226_bib198","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158906","article-title":"Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy","volume":"7","author":"Lin","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib199","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1681\/ASN.0000000000000212","article-title":"Podocyte injury in diabetic kidney disease in mouse models involves TRPC6-mediated calpain activation impairing autophagy","volume":"34","author":"Salemkour","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib200","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","article-title":"Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling","volume":"17","author":"Gross","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib201","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.ymthe.2017.07.014","article-title":"Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy","volume":"25","author":"Echigoya","year":"2017","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib203","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41467-020-16605-x","article-title":"Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5","volume":"11","author":"Yamamura","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib204","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.kint.2022.07.025","article-title":"PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2","volume":"103","author":"Baum","year":"2023","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.gendis.2026.102226_bib205","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2026.102226_bib206","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/1471-2164-9-624","article-title":"Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease","volume":"9","author":"Pandey","year":"2008","journal-title":"BMC Genomics"},{"issue":"26","key":"10.1016\/j.gendis.2026.102226_bib207","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1073\/pnas.1301693110","article-title":"miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease","volume":"110","author":"Patel","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib208","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gendis.2026.102226_bib209","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1681\/ASN.2018030329","article-title":"Effects of enzyme replacement therapy and antidrug antibodies in patients with Fabry disease","volume":"29","author":"Lenders","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gim.2016.122","article-title":"The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat","volume":"19","author":"Benjamin","year":"2017","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib211","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.gendis.2026.102226_bib212","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cpt.790","article-title":"Lucerastat, an iminosugar for substrate reduction therapy: tolerability, pharmacodynamics, and pharmacokinetics in patients with Fabry disease on enzyme replacement","volume":"103","author":"Gu\u00e9rard","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"Gahl","year":"2002","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.gendis.2026.102226_bib214","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM199304223281604","article-title":"Improved renal function in children with cystinosis treated with cysteamine","volume":"328","author":"Markello","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.gendis.2026.102226_bib216","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib217","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfu261","article-title":"Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration","volume":"30","author":"Zoja","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib218","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/s41467-022-32543-2","article-title":"PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression","volume":"13","author":"Lakhia","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib219","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2014.137","article-title":"Translational research in ADPKD: lessons from animal models","volume":"10","author":"Happ\u00e9","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2018.11.048","article-title":"Modeling human digestive diseases with CRISPR-Cas9-modified organoids","volume":"156","author":"Fujii","year":"2019","journal-title":"Gastroenterology"},{"issue":"38","key":"10.1016\/j.gendis.2026.102226_bib221","doi-asserted-by":"crossref","first-page":"eabq0866","DOI":"10.1126\/sciadv.abq0866","article-title":"Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery","volume":"8","author":"Hiratsuka","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib222","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1038\/s41467-018-07594-z","article-title":"3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening","volume":"9","author":"Hale","year":"2018","journal-title":"Nat Commun"},{"issue":"7794","key":"10.1016\/j.gendis.2026.102226_bib223","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"issue":"7785","key":"10.1016\/j.gendis.2026.102226_bib224","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.gendis.2026.102226_bib225","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.gendis.2026.102226_bib226","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem Soc Rev"},{"issue":"13","key":"10.1016\/j.gendis.2026.102226_bib227","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem Soc Rev"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib228","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41581-023-00702-3","article-title":"Cell and gene therapy for kidney disease","volume":"19","author":"Peek","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib229","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/ijms22063014","article-title":"Non-coding RNAs in hereditary kidney disorders","volume":"22","author":"Zhou","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/humu.1163","article-title":"Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome","volume":"18","author":"Hertz","year":"2001","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib231","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000526971","article-title":"Collagen IV and podocyte-related gene variants in patients with concurrent IgA nephropathy and thin basement membrane nephropathy","volume":"147","author":"Xu","year":"2023","journal-title":"Nephron"},{"issue":"11","key":"10.1016\/j.gendis.2026.102226_bib232","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.3390\/ijms25115646","article-title":"Cross-species insights into autosomal dominant polycystic kidney disease: provide an alternative view on research advancement","volume":"25","author":"Luo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib233","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/hmg\/ddt081","article-title":"Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain","volume":"22","author":"Kurbegovic","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"15","key":"10.1016\/j.gendis.2026.102226_bib234","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1074\/jbc.M110.210922","article-title":"Terminal N-linked galactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.gendis.2026.102226_bib235","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.gendis.2026.102226_bib236","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib237","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/viro.1996.0099","article-title":"Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein","volume":"217","author":"Mizukami","year":"1996","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.gendis.2026.102226_bib238","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib239","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrg.2017.97","article-title":"Am I ready for CRISPR? A user's guide to genetic screens","volume":"19","author":"Doench","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"7574","key":"10.1016\/j.gendis.2026.102226_bib240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib241","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajhg.2017.07.014","article-title":"Variant interpretation: functional assays to the rescue","volume":"101","author":"Starita","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"7726","key":"10.1016\/j.gendis.2026.102226_bib242","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib243","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/humu.23223","article-title":"Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing","volume":"38","author":"Borr\u00e0s","year":"2017","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.gendis.2026.102226_bib244","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1681\/ASN.2022010076","article-title":"HNF1B alters an evolutionarily conserved nephrogenic program of target genes","volume":"34","author":"Grand","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/dvdy.22","article-title":"Kidney organoids in translational medicine: disease modeling and regenerative medicine","volume":"249","author":"Miyoshi","year":"2020","journal-title":"Dev Dyn"},{"issue":"10","key":"10.1016\/j.gendis.2026.102226_bib246","doi-asserted-by":"crossref","first-page":"sfae256","DOI":"10.1093\/ckj\/sfae256","article-title":"Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis","volume":"17","author":"Gabai","year":"2024","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib247","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/23120541.00495-2022","article-title":"High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing","volume":"9","author":"Spelier","year":"2023","journal-title":"ERJ Open Res"},{"issue":"7","key":"10.1016\/j.gendis.2026.102226_bib248","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7620","key":"10.1016\/j.gendis.2026.102226_bib249","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib251","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrg3868","article-title":"Methods of integrating data to uncover genotype-phenotype interactions","volume":"16","author":"Ritchie","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gendis.2026.102226_bib252","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.inffus.2018.09.012","article-title":"Machine learning for integrating data in biology and medicine: principles, practice, and opportunities","volume":"50","author":"Zitnik","year":"2019","journal-title":"Inf Fusion"},{"issue":"13","key":"10.1016\/j.gendis.2026.102226_bib253","doi-asserted-by":"crossref","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","article-title":"Modeling polypharmacy side effects with graph convolutional networks","volume":"34","author":"Zitnik","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gendis.2026.102226_bib254","doi-asserted-by":"crossref","DOI":"10.1177\/2374289519873088","article-title":"Artificial intelligence and machine learning in pathology: the present landscape of supervised methods","volume":"6","author":"Rashidi","year":"2019","journal-title":"Acad Pathol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.gendis.2026.102226_bib256","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2021.11.029","article-title":"Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury","volume":"341","author":"Tang","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.gendis.2026.102226_bib257","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/nano6010008","article-title":"Targeted sterically stabilized phospholipid siRNA nanomedicine for hepatic and renal fibrosis","volume":"6","author":"Khaja","year":"2016","journal-title":"Nanomaterials (Basel)"},{"issue":"12","key":"10.1016\/j.gendis.2026.102226_bib258","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.ymthe.2022.11.007","article-title":"Secondary hemophagocytic lymphohistiocytosis following Zolgensma therapy: an evolving story on the innate response to systemic gene therapy","volume":"30","author":"Byrne","year":"2022","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib259","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.kint.2016.10.027","article-title":"APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy","volume":"91","author":"Robinson","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.gendis.2026.102226_bib260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.kint.2016.09.033","article-title":"Strict blood pressure control associates with decreased mortality risk by APOL1 genotype","volume":"91","author":"Ku","year":"2017","journal-title":"Kidney Int"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:47:27Z","timestamp":1792770447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304226001984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":260,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2027,2]]}},"alternative-id":["S2352304226001984"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102226","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic kidney diseases: Decoding molecular taxonomies to drive precision nephrology and therapeutic innovation","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102226"}}